Literature DB >> 2467774

Antibody binding of macromolecular DNA and RNA in the plasma of SLE patients.

F Krapf1, M Herrmann, W Leitmann, J R Kalden.   

Abstract

Plasmapheresis fluids from 20 patients with clinically active SLE, from three patients with Waldenstrom's disease, from three patients with rheumatoid arthritis, two patients with myasthenia gravis and other diseases including active systemic disorders were precipitated using polyethylene glycol 6000 (PEG). By applying ethidium bromide staining, plasma nucleic acids (PNA) could be demonstrated in PEG-precipitates of SLE patients exclusively. Purified immunoglobulins of SLE plasma precipitates were shown to form antigen-antibody complexes with PNA as demonstrated by electronmicroscopy. Further characterization of PNA by agarose gel electrophoresis revealed a molecular weight up to 20 kbp. Cesium chloride buoyant density gradients showed non-homogeneous molecules, excluding pure microbial origin. In spite of RNase digestion, the PNA contained RNA with 30-70% riboguanosine as shown by nucleoside analysis. The high amount of guanosine-rich RNA was further supported by similarities between PNA and polyriboguanylic acid in hyperchrome shifting due to thermic denaturation. HPLC analysis showed a molecular weight of ribonucleic acids of more than 60 b thus excluding mere oligonucleotides. In contrast to B-type dsDNA, PNA from SLE patients were immunogenic. Antibodies against PNA could be induced in rabbits by subcutaneous injection. The antisera thus obtained showed crossreactivity with polyriboguanylic acid and dsDNA preparations.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2467774      PMCID: PMC1541953     

Source DB:  PubMed          Journal:  Clin Exp Immunol        ISSN: 0009-9104            Impact factor:   4.330


  19 in total

1.  Free DNA in serum and plasma from normal adults.

Authors:  C R Steinman
Journal:  J Clin Invest       Date:  1975-08       Impact factor: 14.808

2.  Appearance of circulating DNA during hemodialysis.

Authors:  C R Steinman; A Ackad
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

3.  Vegetative lambda DNA. IV. Fractionation of replicating lambda DNA on benzoylated-naphthoylated DEAE cellulose.

Authors:  J A Kiger; R L Sinsheimer
Journal:  J Mol Biol       Date:  1969-03-28       Impact factor: 5.469

4.  Quantitative reversed-phase high performance liquid chromatographic determination of major and modified deoxyribonucleosides in DNA.

Authors:  K C Kuo; R A McCune; C W Gehrke; R Midgett; M Ehrlich
Journal:  Nucleic Acids Res       Date:  1980-10-24       Impact factor: 16.971

5.  Sequence and organization of the human mitochondrial genome.

Authors:  S Anderson; A T Bankier; B G Barrell; M H de Bruijn; A R Coulson; J Drouin; I C Eperon; D P Nierlich; B A Roe; F Sanger; P H Schreier; A J Smith; R Staden; I G Young
Journal:  Nature       Date:  1981-04-09       Impact factor: 49.962

6.  Circulating DNA:anti-DNA complexes in systemic lupus erythematosus. Detection and characterization by ultracentrifugation.

Authors:  C Bruneau; J Benveniste
Journal:  J Clin Invest       Date:  1979-07       Impact factor: 14.808

7.  Direct evidence for circulating DNA/anti-DNA complexes in systemic lupus erythematosus.

Authors:  J S Davis; S M Godfrey; J B Winfield
Journal:  Arthritis Rheum       Date:  1978 Jan-Feb

8.  Novel DNA-protein complex and a large DNA in SLE cryoprecipitates.

Authors:  M Rieber; C E Contreras; M S Rieber; N E Bianco
Journal:  Clin Exp Immunol       Date:  1986-10       Impact factor: 4.330

9.  Reaction of systemic lupus erythematosus antinative DNA antibodies with native DNA fragments from 20 to 1,200 base pairs.

Authors:  M Papalian; E Lafer; R Wong; B D Stollar
Journal:  J Clin Invest       Date:  1980-02       Impact factor: 14.808

10.  Failure to detect circulating DNA--anti-DNA complexes by four radioimmunological methods in patients with systemic lupus erythematosus.

Authors:  S Izui; P H Lambert; P A Miescher
Journal:  Clin Exp Immunol       Date:  1977-12       Impact factor: 4.330

View more
  7 in total

1.  Patients with systemic lupus erythematosus (SLE) have a circulating inducer of interferon-alpha (IFN-alpha) production acting on leucocytes resembling immature dendritic cells.

Authors:  H Vallin; S Blomberg; G V Alm; B Cederblad; L Rönnblom
Journal:  Clin Exp Immunol       Date:  1999-01       Impact factor: 4.330

Review 2.  Towards a pro-resolving concept in systemic lupus erythematosus.

Authors:  Sebastian Boeltz; Melanie Hagen; Jasmin Knopf; Aparna Mahajan; Maximilian Schick; Yi Zhao; Cornelia Erfurt-Berge; Jürgen Rech; Luis E Muñoz; Martin Herrmann
Journal:  Semin Immunopathol       Date:  2019-11-06       Impact factor: 9.623

3.  Complexes of serum amyloid P component and DNA in serum from healthy individuals and systemic lupus erythematosus patients.

Authors:  I J Sørensen; E Holm Nielsen; L Schrøder; A Voss; L Horváth; S E Svehag
Journal:  J Clin Immunol       Date:  2000-11       Impact factor: 8.317

Review 4.  Pathogenesis of SLE: immunopathology in man.

Authors:  J R Kalden; T H Winkler; M Herrmann; F Krapf
Journal:  Rheumatol Int       Date:  1991       Impact factor: 2.631

Review 5.  CpG DNA: a pathogenic factor in systemic lupus erythematosus?

Authors:  A M Krieg
Journal:  J Clin Immunol       Date:  1995-11       Impact factor: 8.317

6.  Requirement for DNA CpG content in TLR9-dependent dendritic cell activation induced by DNA-containing immune complexes.

Authors:  Kei Yasuda; Christophe Richez; Melissa B Uccellini; Rocco J Richards; Ramon G Bonegio; Shizuo Akira; Marc Monestier; Ronald B Corley; Gregory A Viglianti; Ann Marshak-Rothstein; Ian R Rifkin
Journal:  J Immunol       Date:  2009-07-31       Impact factor: 5.422

7.  Are retroviruses involved in the pathogenesis of SLE? Evidence demonstrated by molecular analysis of nucleic acids from SLE patients' plasma.

Authors:  F E Krapf; M Herrmann; W Leitmann; J R Kalden
Journal:  Rheumatol Int       Date:  1989       Impact factor: 2.631

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.